Methotrexate Chronotherapy is Effective Against Rheumatoid Arthritis

REFERENCES

• Abe C, Mitsunaga K, Shiokawa Y. (1980). Spontaneous polyarthritis in MRL/l mice. Ryumachi 20:233–239.
   PubMedGoogle Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315–324.
   PubMed Web of Science ®Google Scholar
• Arvidson NG, Gudbjornsson B, Larsson A, Hallgren R. (1997). The timing of glucocorticoid administration in rheumatoid arthritis. Ann. Rheum. Dis. 56:27–31.
   PubMed Web of Science ®Google Scholar
• Balis FM, Jeffries SL, Lange B, Murphy RF, Doherty KM, Arndt CA, Luery N, Poplack DG. (1989). Chronopharmacokinetics of oral methotrexate and 6-mercaptopurine: is there diurnal variation in the disposition of antileukemic therapy? Am. J. Pediatr. Hematol. Oncol. 11:324–326.
   PubMedGoogle Scholar
• Becker C, Barbulescu K, Hildner K, Meyer zum Büschenfelde KH, Neurath MF. (1998). Activation and methotrexate-mediated suppression of the TNFα promoter in T cells and macrophages. Ann. N. Y. Acad. Sci. 859:219–222.
   PubMedGoogle Scholar
• Bellamy N, Sothern RB, Campbell J, Buchanan WW. (1991). Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. Ann. Rheum. Dis. 50:243–248.
   PubMed Web of Science ®Google Scholar
• Bellamy N, Sothern RB, Campbell J, Buchanan WW. (2002). Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann. Rheum. Dis. 61:1075–1080.
   PubMed Web of Science ®Google Scholar
• Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E. (2008). Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 371:205–214.
   PubMed Web of Science ®Google Scholar
• Carpentier N, Bertin P, Marquet P, Sabot C, Bonnet C, Debord J, Lachâtre G, Trèves R. (1998). Is there an optimal time to administer methotrexate in the treatment of rheumatoid arthritis? J. Rheumatol. 25:1270–1275.
   PubMedGoogle Scholar
• Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F. (2002). Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173–1177.
   PubMed Web of Science ®Google Scholar
• Chu CQ, Field M, Feldmann M, Maini RN. (1991). Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34:1125–1132.
   PubMed Web of Science ®Google Scholar
• Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V. (2001). Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthritis Rheum. 44:1984–1992.
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, Gold PW, Chrousos GP, Wilder RL. (1997). Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 82:1279–1283.
   PubMed Web of Science ®Google Scholar
• D'Alonzo GE, Smolensky MH, Feldman S, Gnosspelius Y, Karlsson K. (1995). Bambuterol in the treatment of asthma: a placebo-controlled comparison of once-daily morning vs. evening administration. Chest 107:406–412.
   PubMedGoogle Scholar
• Fransen J, van Riel PL. (2005). The Disease Activity Score and the EULAR response criteria. Clin. Exp. Rheumatol. 23:S93–S99.
   PubMed Web of Science ®Google Scholar
• Haus E. (2007). Chronobiology in the endocrine system. Adv. Drug Deliv. Rev. 59:985–1014.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón Fernández JR. (2010). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC Study. Chronobiol. Int. 27:1629–1651.
   PubMed Web of Science ®Google Scholar
• Herold M, Günther R. (1987). Circadian rhythm of C-reactive protein in patients with rheumatoid arthritis. Prog. Clin. Biol. Res. 227B:271–279.
   PubMedGoogle Scholar
• Kodama A, To H, Kinoshita T, Ieiri I, Higuchi S. (2009). Influence of dosing schedules on toxicity and antitumour effects of combined cisplatin and docetaxel treatment in mice. J. Pharm. Pharmacol. 61:615–621.
   PubMedGoogle Scholar
• Koopman WJ, Gay S. (1988). The MRL-lpr/lpr mouse. A model for the study of rheumatoid arthritis. Scand. J. Rheumatol. 75( Suppl):284–289.
   Google Scholar
• Kowanko IC, Knapp MS, Pownall R, Swannell AJ. (1982). Domiciliary self-measurement in rheumatoid arthritis and the demonstration of circadian rhythmicity. Ann. Rheum. Dis. 41:453–455.
   PubMed Web of Science ®Google Scholar
• Kremer JM, Phelps CT. (1992). Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum. 35:138–145.
   PubMed Web of Science ®Google Scholar
• Lévi F, Zidani R, Misset JL. (1997). Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 350:681–686.
   PubMed Web of Science ®Google Scholar
• Marinova-Mutafchieva L, Williams RO, Mason LJ, Mauri C, Feldmann M, Maini RN. (1997). Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin. Exp. Immunol. 107:507–512.
   PubMedGoogle Scholar
• Mussener A, Litton MJ, Lindroos E, Klareskog L. (1997). Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA). Clin. Exp. Immunol. 107:485–493.
   PubMed Web of Science ®Google Scholar
• Ohdo S, Inoue K, Yukawa E, Higuchi S, Nakano S, Ogawa N. (1997). Chronotoxicity of methotrexate in mice and its relation to circadian rhythm of DNA synthesis and pharmacokinetics. Jpn. J. Pharmacol. 75:283–290.
   PubMedGoogle Scholar
• Perry MG, Kirwan JR, Jessop DS, Hunt LP. (2009). Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis. Ann. Rheum. Dis. 68:63–68.
   PubMed Web of Science ®Google Scholar
• Pincus T, Summey JA, Soraci SA , Wallston KA, Hummon NP. (1983). Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 26:1346–1353.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911–1929.
   PubMed Web of Science ®Google Scholar
• Rivard GE, Infante-Rivard C, Dresse MF, Leclerc JM, Champagne J. (1993). Circadian time-dependent response of childhood lymphoblastic leukemia to chemotherapy: a long-term follow-up study of survival. Chronobiol. Int. 10:201–204.
   PubMed Web of Science ®Google Scholar
• Robinson BA, Begg EJ, Colls BM, Jeffery GM, Sharman JR. (1989). Circadian pharmacokinetics of methotrexate. Cancer Chemother. Pharmacol. 24:397–399.
   PubMedGoogle Scholar
• Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y. (1991). Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study. Arterioscler. Thromb. 11:816–826.
   PubMedGoogle Scholar
• Schmiegelow K, Glomstein A, Kristinsson J, Salmi T, Schrøder H, Björk O. (1997). Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO). J. Pediatr. Hematol. Oncol. 19:102–109.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Lemmer B, Reinberg AE. (2007). Chronobiology and chronotherapy of allergic disease and bronchial asthma. Adv. Drug Deliv. Rev. 59:828–851.
   PubMed Web of Science ®Google Scholar
• Sulli A, Maestroni GJ, Villaggio B, Hertens E, Craviotto C, Pizzorni C. (2002). Melatonin serum levels in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 966:276–283.
   PubMed Web of Science ®Google Scholar
• Tabuchi M, To H, Sakaguchi H, Goto N, Takeuchi A, Higuchi S, Ohdo S. (2005). Therapeutic index by combination of adriamycin and docetaxel depends on dosing time in mice. Cancer Res. 65:8448–8454.
   PubMed Web of Science ®Google Scholar
• To H, Irie S, Tomonari M, Watanabe Y, Kitahara T, Sasaki H. (2009). Therapeutic index of methotrexate depends on circadian cycling of tumor necrosis factor-α in collagen-induced arthritis rats and mice. J. Pharm. Pharmacol. 61:1333–1338.
   PubMed Web of Science ®Google Scholar
• van Gestel AM, Prevoo ML, van ‘t Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. (1996). Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 39:34–40.
   PubMed Web of Science ®Google Scholar
• Weinblatt ME, Weissman BN, Holdsworth DE, Fraser PA, Maier AL, Falchuk KR, Coblyn JS. (1992). Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum. 35:129–137.
   PubMed Web of Science ®Google Scholar
• Williams AS, Topley N, Dojcinov S, Richards PJ, Williams BD. (2001). Amelioration of rat antigen-induced arthritis by liposomally conjugated methotrexate is accompanied by down-regulation of cytokine mRNA expression. Rheumatology 40:375–383.
   PubMed Web of Science ®Google Scholar